The report "Empty Capsules Market by Type (Gelatin (Porcine, Bovine, Bonemeal), Non-gelatin (HPMC, Starch)), Functionality (Immediate-release, Sustained-Release, Delayed-release),Therapeutic Application (Antibiotic, Dietary, Antacid, CVD) - Global Forecast to 2029", is projected to reach USD 4.2 billion by 2029 from an estimated USD 3.1 billion in 2024, at a CAGR of 6.3% during the forecast period. Expansion of the Over-the-counter medications, increasing demand for nutraceuticals, and benefits of capsules over other dosage forms are the major driving factors of the empty capsules market. However, issues related to the safety and side effects of gelatin capsules and cultural practices and dietary restrictions are the major restraining factors of the empty capsules market.
Browse 356 market data Tables and 48 Figures spread through 333 Pages and in-depth TOC on "Empty Capsules Market by Type (Gelatin (Porcine, Bovine, Bonemeal), Non-gelatin (HPMC, Starch)), Functionality (Immediate-release, Sustained-Release, Delayed-release),Therapeutic Application (Antibiotic, Dietary, Antacid, CVD) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.html
The gelatin capsules segment accounted for the largest share by type in the empty capsules market in 2023.
By type, the empty capsules market has been further categorized as gelatin capsules and non-gelatin capsules. The gelatin capsules segment is further sub-segmented into porcine gelatin, bovine-derived gelatin, bone meal, and other gelatin sources. The non-gelatin segment is further categorized as including hydroxypropyl methylcellulose (HPMC) capsules and pullulan & starch capsules. The gelatin segment accounted for the largest share of the market in 2023 due to their excellent biocompatibility and ability to effectively encapsulate a wide range of active ingredients, making them a preferred choice in pharmaceuticals and nutraceuticals. Furthermore, their ease of production and cost-effectiveness enhance their appeal in these industries.
The immediate-release capsules segment is expected to grow at a higher rate during the forecast period.
Based on functionality, the empty capsules market has been segmented into immediate-release capsules, sustained-release capsules, and delayed-release capsules. In 2023, the immediate-release capsules segment accounted for the largest share of the empty capsules market and is expected to grow at a higher growth rate during the forecast period of 2024-2029. The immediate-release empty capsules can provide a rapid onset of action, which is crucial for treating acute conditions, and their widespread use in over-the-counter and prescription medications is expected to drive the segment during the forecast period. Additionally, their compatibility with various drug formulations and cost-effective production further boost their market demand.
The antibiotic & antibacterial drugs segment accounted for the largest share of the therapeutic application segment in the empty capsules market in 2022.
Based on therapeutic application, the empty capsules market has been segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, other therapeutic applications. In 2023, the antibiotic & antibacterial drugs segment accounted for the largest share of the empty capsules market. Antibiotic and antibacterial drugs can protect sensitive active ingredients from degradation, ensuring optimal efficacy and their suitability for precise dosing, facilitating accurate administration; these factors are expected to drive the segment’s growth. Additionally, the rising incidence of bacterial infections and the need for effective and convenient treatment options contribute to their market demand.
The North American region accounted for the largest share of the empty capsules market in 2023.
The empty capsules market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), the Middle East, and Africa. North America region accounted for the largest share of the global empty capsules market in 2023. Factors such as increasing consumer awareness of health and wellness and a growing preference for dietary supplements have contributed to the market's growth. However, the empty capsules market in the Asia Pacific region is expected to grow at a higher rate during 2024-2029. The growth of the empty capsules market in Asia Pacific is driven by the rising demand for dietary supplements, the increasing prevalence of chronic diseases, and the expansion of the pharmaceutical industry. Additionally, advancements in capsule delivery technologies and a growing preference for capsule-based drug delivery systems contribute to market expansion.
Key players in the empty capsules market include Capsugel (Lonza) (Switzerland), ACG (India), QUALICAPS (Roquette Frères) (France), SUHEUNG (South Korea), Shanxi Guangsheng Capsule Limited (China), CapsCanada (Lyfe Group) (US), HealthCaps India (India), Nectar Lifesciences Ltd. (India), Sunil Healthcare Limited (India), Farmacápsulas (Colombia), NATURAL CAPSULES LIMITED (India), Erawat Pharma Limited (India), Qingdao Yiqing Biotechnology Co., Ltd. (Baotou Dongbao Bio-Tech Co., Ltd.) (China), Fortcaps ( Kumar Organic Products Limited) (India), Comed Chemicals Limited (India), Roxlor (US), Medisca Inc. (US), Zhejiang Yuexi Capsule Co. (China), ZHEJIANG HUILI CAPSULES CO., LTD (China), Shaoxing Zhongya Capsule Co., Ltd. (China), Shing Lih Fang Enterprise Co., Ltd. (Taiwan), Chemcaps Limited (India), SNAIL PHARMA INDUSTRY (China), SavoiurCaps (India), Shanxi JC Biological Technology CO. (China), Shaoxing Kangke Capsule Co., Ltd. (China), Lefancaps (Canada), BIO-CAPS INDIA LTD. (India), BioCaps Enterprise (US), Bright Pharma Caps (US), and SHREE PHARMA CAPS (India).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
